Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation
Clinical trial NCT01087294 · COMPLETED
Trial details
- NCT number
- NCT01087294
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-04
- Primary completion
- 2024-03-08
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.